<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Miri M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>To obtain endolysin with impact(s) on gram-negative bacteria as well as gram-positive bacteria, N-acetylmuramyl L-alanine-amidase (MurNAc-LAA) from a &lt;i>Bacillus subtilis&lt;/i>-hosted Siphoviridae phage (SPP1 phage, Subtilis Phage Pavia 1) was exogenously expressed in &lt;i>Escherichia coli (E. coli)&lt;/i>.&lt;h4>Methods&lt;/h4>The sequences of &lt;i>MurNAc-LAA&lt;/i> genes encoding peptidoglycan hydrolases were obtained from the Virus-Host database. The sequence of MurNAc-LAA was optimized by GenScript software to generate MurNAc-LAA-MMI (LysM2) for optimal expression in &lt;i>E. coli&lt;/i>. Furthermore, the structure and function of LysM2 was evaluated &lt;i>in silico&lt;/i>. The optimized gene was synthesized, subcloned in the pET28a, and expressed in &lt;i>E. coli&lt;/i> BL21(DE3). The antibacterial effects of the protein on the peptidoglycan substrates were studied.&lt;h4>Results&lt;/h4>&lt;i>LysM2&lt;/i>, on 816 &lt;i>bp&lt;/i> gene encoding a 33 &lt;i>kDa&lt;/i> protein was confirmed as specific SPP1 phage enzyme. The enzyme is composed of 271 amino acids, with a half-life of 10 &lt;i>hr&lt;/i> in &lt;i>E. coli&lt;/i>. &lt;i>In silico&lt;/i> analyses showed 34.2% alpha-helix in the secondary structure, hydrophobic N-terminal, and lysine-rich C-terminal, and no antigenic properties in LysM2 protein. This optimized endolysin revealed impacts against &lt;i>Proteus&lt;/i> (sp) by turbidity, and an antibacterial activity against &lt;i>Klebsiella pneumoniae, Salmonella typhimurium&lt;/i>, and &lt;i>Proteus vulgaris&lt;/i> in agar diffusion assays.&lt;h4>Conclusion&lt;/h4>Taken together, our results confirmed that LysM2 is an inhibiting agent for gram-negative bacteria.</pubmed_abstract><journal>Avicenna journal of medical biotechnology</journal><pagination>46-53</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9017466</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exogenous Production of N-acetylmuramyl-L Alanine Amidase (LysM2) from Siphoviridae Phage Affecting Anti-Gram-Negative Bacteria: Evaluation of Its Structure and Function.</pubmed_title><pmcid>PMC9017466</pmcid><pubmed_authors>Miri M</pubmed_authors><pubmed_authors>Darvish Alipour Astaneh S</pubmed_authors><pubmed_authors>Yazdianpour S</pubmed_authors><pubmed_authors>Abolmaali S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exogenous Production of N-acetylmuramyl-L Alanine Amidase (LysM2) from Siphoviridae Phage Affecting Anti-Gram-Negative Bacteria: Evaluation of Its Structure and Function.</name><description>&lt;h4>Background&lt;/h4>To obtain endolysin with impact(s) on gram-negative bacteria as well as gram-positive bacteria, N-acetylmuramyl L-alanine-amidase (MurNAc-LAA) from a &lt;i>Bacillus subtilis&lt;/i>-hosted Siphoviridae phage (SPP1 phage, Subtilis Phage Pavia 1) was exogenously expressed in &lt;i>Escherichia coli (E. coli)&lt;/i>.&lt;h4>Methods&lt;/h4>The sequences of &lt;i>MurNAc-LAA&lt;/i> genes encoding peptidoglycan hydrolases were obtained from the Virus-Host database. The sequence of MurNAc-LAA was optimized by GenScript software to generate MurNAc-LAA-MMI (LysM2) for optimal expression in &lt;i>E. coli&lt;/i>. Furthermore, the structure and function of LysM2 was evaluated &lt;i>in silico&lt;/i>. The optimized gene was synthesized, subcloned in the pET28a, and expressed in &lt;i>E. coli&lt;/i> BL21(DE3). The antibacterial effects of the protein on the peptidoglycan substrates were studied.&lt;h4>Results&lt;/h4>&lt;i>LysM2&lt;/i>, on 816 &lt;i>bp&lt;/i> gene encoding a 33 &lt;i>kDa&lt;/i> protein was confirmed as specific SPP1 phage enzyme. The enzyme is composed of 271 amino acids, with a half-life of 10 &lt;i>hr&lt;/i> in &lt;i>E. coli&lt;/i>. &lt;i>In silico&lt;/i> analyses showed 34.2% alpha-helix in the secondary structure, hydrophobic N-terminal, and lysine-rich C-terminal, and no antigenic properties in LysM2 protein. This optimized endolysin revealed impacts against &lt;i>Proteus&lt;/i> (sp) by turbidity, and an antibacterial activity against &lt;i>Klebsiella pneumoniae, Salmonella typhimurium&lt;/i>, and &lt;i>Proteus vulgaris&lt;/i> in agar diffusion assays.&lt;h4>Conclusion&lt;/h4>Taken together, our results confirmed that LysM2 is an inhibiting agent for gram-negative bacteria.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan-Mar</publication><modification>2025-04-18T12:11:18.232Z</modification><creation>2025-04-06T21:49:23.936Z</creation></dates><accession>S-EPMC9017466</accession><cross_references><pubmed>35509364</pubmed><doi>10.18502/ajmb.v14i1.8169</doi></cross_references></HashMap>